source
- FDA issues request for information on early-phase ibogaine trial designThe FDA announced a request for information (RFI) to gather input on how to design early-phase clinical trials of ibogaine drug products. The agency is looking for comments on protocol elements su…
- Australia's TGA begins five-year transition to new medicine labeling standardsThe Therapeutic Goods Administration has adopted two new labeling standards for medicines in Australia. The standards will become mandatory after a five-year transition period that starts now. Ph…